Westwood Management Corporation’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Westwood Management Corporation’s Portfolio PGNX Stock Details PGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-12,000	Closed	-$96K	–	82
2018 Q2	$96K	Hold	12,000	–	–	0.01%	76
2018 Q1	$90K	Hold	12,000	–	–	0.01%	78
2017 Q4	$71K	Hold	12,000	–	–	0.01%	78
2017 Q3	$88K	Hold	12,000	–	–	0.01%	78
2017 Q2	$81K	Hold	12,000	–	–	0.01%	78
2017 Q1	$113K	Hold	12,000	–	–	0.02%	81
2016 Q4	$104K	Sell	12,000 -8,000	-40%	-$59.1K	0.02%	75
2016 Q3	$127K	Buy	+20,000	New	+$121K	0.02%	76

Other funds holding PGNX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

CTA

Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Westwood Management Corporation's PGNX Position: Q3 2018 in Review

Westwood Management Corporation sold out of Progenics Pharmaceuticals Inc (PGNX) in Q3 2018, closing a stake of 12,000 shares — an estimated $96K sold.

Westwood Management Corporation first reported a position in PGNX in Q3 2016 and held it in 8 quarters. The position peaked at $127K in Q3 2016. 149 funds tracked by Wall St. Rank hold PGNX as of Q3 2018.

Westwood Management Corporation reported no remaining Progenics Pharmaceuticals Inc position as of Q3 2018 after selling out during the quarter.
Westwood Management Corporation sold 12,000 Progenics Pharmaceuticals Inc shares in Q3 2018, an estimated $96K.
Westwood Management Corporation first reported a position in Progenics Pharmaceuticals Inc in Q3 2016 and held it in 8 quarters.
Westwood Management Corporation's Progenics Pharmaceuticals Inc position peaked at $127K in Q3 2016.
149 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q3 2018.

Based on Westwood Management Corporation's 13F filing for Q3 2018, filed 26 Oct 2018.